ID   MK_RAT                  Reviewed;         140 AA.
AC   Q9R1S9;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2024, entry version 126.
DE   RecName: Full=Midkine {ECO:0000303|PubMed:10683378, ECO:0000303|PubMed:11136554};
DE            Short=MK {ECO:0000303|PubMed:10683378};
DE   Flags: Precursor;
GN   Name=Mdk {ECO:0000312|RGD:69073};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=10683378; DOI=10.1172/jci7208;
RA   Horiba M., Kadomatsu K., Nakamura E., Muramatsu H., Ikematsu S., Sakuma S.,
RA   Hayashi K., Yuzawa Y., Matsuo S., Kuzuya M., Kaname T., Hirai M., Saito H.,
RA   Muramatsu T.;
RT   "Neointima formation in a restenosis model is suppressed in midkine-
RT   deficient mice.";
RL   J. Clin. Invest. 105:489-495(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Fetal adrenal gland;
RX   PubMed=11136554; DOI=10.1006/mgme.2000.3111;
RA   Dewing P., Ching S.T., Zhang Y.-H., Huang B.-L., Peirce R.M.,
RA   McCabe E.R.B., Vilain E.;
RT   "Midkine is expressed early in rat fetal adrenal development.";
RL   Mol. Genet. Metab. 71:616-622(2000).
RN   [3]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=1768439; DOI=10.3109/08977199109000275;
RA   Kretschmer P.J., Fairhurst J.L., Decker M.M., Chan C.P., Gluzman Y.,
RA   Boehlen P., Kovesdi I.;
RT   "Cloning, characterization and developmental regulation of two members of a
RT   novel human gene family of neurite outgrowth-promoting proteins.";
RL   Growth Factors 5:99-114(1991).
CC   -!- FUNCTION: Developmentally regulated, secreted growth factor homologous
CC       to pleiotrophin (PTN), which has heparin binding activity. Binds
CC       anaplastic lymphoma kinase (ALK) which induces ALK activation and
CC       subsequent phosphorylation of the insulin receptor substrate (IRS1),
CC       followed by the activation of mitogen-activated protein kinase (MAPK)
CC       and PI3-kinase, and the induction of cell proliferation. Involved in
CC       neointima formation after arterial injury, possibly by mediating
CC       leukocyte recruitment. Also involved in early fetal adrenal gland
CC       development (By similarity). {ECO:0000250, ECO:0000269|PubMed:10683378,
CC       ECO:0000269|PubMed:11136554}.
CC   -!- FUNCTION: Secreted protein that functions as a cytokine and growth
CC       factor and mediates its signal through cell-surface proteoglycan and
CC       non-proteoglycan receptors. Binds cell-surface proteoglycan receptors
CC       via their chondroitin sulfate (CS) groups. Thereby regulates many
CC       processes like inflammatory response, cell proliferation, cell
CC       adhesion, cell growth, cell survival, tissue regeneration, cell
CC       differentiation and cell migration. Participates in inflammatory
CC       processes by exerting two different activities (By similarity).
CC       Firstly, mediates neutrophils and macrophages recruitment to the sites
CC       of inflammation both by direct action by cooperating namely with ITGB2
CC       via LRP1 and by inducing chemokine expression (PubMed:10683378). This
CC       inflammation can be accompanied by epithelial cell survival and smooth
CC       muscle cell migration after renal and vessel damage, respectively.
CC       Secondly, suppresses the development of tolerogenic dendric cells
CC       thereby inhibiting the differentiation of regulatory T cells and also
CC       promote T cell expansion through NFAT signaling and Th1 cell
CC       differentiation (By similarity). Promotes tissue regeneration after
CC       injury or trauma. After heart damage negatively regulates the
CC       recruitment of inflammatory cells and mediates cell survival through
CC       activation of anti-apoptotic signaling pathways via MAPKs and AKT
CC       pathways through the activation of angiogenesis. Also facilitates liver
CC       regeneration as well as bone repair by recruiting macrophage at trauma
CC       site and by promoting cartilage development by facilitating chondrocyte
CC       differentiation. Plays a role in brain by promoting neural precursor
CC       cells survival and growth through interaction with heparan sulfate
CC       proteoglycans (By similarity). Binds PTPRZ1 and promotes neuronal
CC       migration and embryonic neurons survival. Binds SDC3 or GPC2 and
CC       mediates neurite outgrowth and cell adhesion. Binds chondroitin sulfate
CC       E and heparin leading to inhibition of neuronal cell adhesion induced
CC       by binding with GPC2 (By similarity). Binds CSPG5 and promotes
CC       elongation of oligodendroglial precursor-like cells (By similarity).
CC       Also binds ITGA6:ITGB1 complex; this interaction mediates MDK-induced
CC       neurite outgrowth. Binds LRP1; promotes neuronal survival. Binds
CC       ITGA4:ITGB1 complex; this interaction mediates MDK-induced osteoblast
CC       cells migration through PXN phosphorylation. Binds anaplastic lymphoma
CC       kinase (ALK) which induces ALK activation and subsequent
CC       phosphorylation of the insulin receptor substrate (IRS1), followed by
CC       the activation of mitogen-activated protein kinase (MAPK) and PI3-
CC       kinase, and the induction of cell proliferation. Promotes epithelial to
CC       mesenchymal transition through interaction with NOTCH2 (By similarity).
CC       During arteriogenesis, plays a role in vascular endothelial cell
CC       proliferation by inducing VEGFA expression and release which in turn
CC       induces nitric oxide synthase expression. Moreover activates
CC       vasodilation through nitric oxide synthase activation. Negatively
CC       regulates bone formation in response to mechanical load by inhibiting
CC       Wnt/beta-catenin signaling in osteoblasts (By similarity). In addition
CC       plays a role in hippocampal development, working memory, auditory
CC       response, early fetal adrenal gland development and the female
CC       reproductive system (By similarity) (PubMed:11136554).
CC       {ECO:0000250|UniProtKB:P12025, ECO:0000250|UniProtKB:P21741,
CC       ECO:0000269|PubMed:10683378, ECO:0000269|PubMed:11136554}.
CC   -!- SUBUNIT: Homodimer. Interacts with ALK. Interacts with LRP1; promotes
CC       neuronal survival. Interacts with LRP2. Interacts with NCAM1. Interacts
CC       (via C-terminal) with PTPRZ1 (via chondroitin sulfate chains); this
CC       interaction is inhibited by PTN; this interaction promotes neuronal
CC       migration. Interacts with NCL; this interaction promotes NCL clustering
CC       and lateral movements of this complex into lipid rafts leading to MDK
CC       internalization. Interacts with LRP6 and LRP8: this interaction is
CC       calcium dependent. Interacts with ITGA4. Interacts with ITGA6.
CC       Interacts with ITGB1. Interacts with ITGA4:ITGB1 complex; this
CC       interaction mediates MDK-induced osteoblast cells migration through PXN
CC       phosphorylation. Interacts with ITGA6:ITGB1 complex; this interaction
CC       mediates MDK-induced neurite outgrowth. Interacts with NOTCH2; this
CC       interactio mediates a nuclear accumulation of NOTCH2 and therefore
CC       activation of NOTCH2 signaling leading to interaction between HES1 and
CC       STAT3. Interacts with GPC2 (via heparan sulfate chain); this
CC       interaction is inhibited by heparin followed by chondroitin sulfate E;
CC       this interaction induces GPC2 clustering through heparan sulfate chain;
CC       this interaction induces neuronal cell adhesion and neurite outgrowth.
CC       Interacts with SDC3; this interaction induces SDC3 clustering; this
CC       interaction induces neuronal cell adhesion and neurite outgrowth (By
CC       similarity). Interacts with SDC1 (By similarity). Interacts with CSPG5;
CC       this interaction promotes elongation of oligodendroglial precursor-like
CC       cells (By similarity). {ECO:0000250|UniProtKB:P12025,
CC       ECO:0000250|UniProtKB:P21741}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed at a low level in arteries, and at higher
CC       levels in newly formed neointima. In brain, expressed in the caudate
CC       nucleus and the brain stem. {ECO:0000269|PubMed:10683378,
CC       ECO:0000269|PubMed:1768439}.
CC   -!- DEVELOPMENTAL STAGE: In the cortices of the adrenal glands, expressed
CC       at 12.5 dpc, decreases considerably at 15.5 dpc and is almost
CC       undetectable in the newborn stage. In brain, expressed at low levels in
CC       early embryos, expression peaks between 12 dpc and 14 dpc, and rapidly
CC       falls until birth when expression is barely detectable.
CC       {ECO:0000269|PubMed:11136554, ECO:0000269|PubMed:1768439}.
CC   -!- INDUCTION: In arteries 3 days after injury. Expression continues to
CC       increase until day 7 after injury and decreases slightly by day 14.
CC       {ECO:0000269|PubMed:10683378}.
CC   -!- SIMILARITY: Belongs to the pleiotrophin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB025023; BAA83783.1; -; mRNA.
DR   EMBL; AF315950; AAG45151.1; -; mRNA.
DR   RefSeq; NP_110486.1; NM_030859.2.
DR   RefSeq; XP_006234654.1; XM_006234592.2.
DR   RefSeq; XP_006234655.1; XM_006234593.3.
DR   AlphaFoldDB; Q9R1S9; -.
DR   SMR; Q9R1S9; -.
DR   BioGRID; 249514; 4.
DR   IntAct; Q9R1S9; 1.
DR   STRING; 10116.ENSRNOP00000036207; -.
DR   PhosphoSitePlus; Q9R1S9; -.
DR   PaxDb; 10116-ENSRNOP00000036207; -.
DR   GeneID; 81517; -.
DR   KEGG; rno:81517; -.
DR   UCSC; RGD:69073; rat.
DR   AGR; RGD:69073; -.
DR   CTD; 4192; -.
DR   RGD; 69073; Mdk.
DR   VEuPathDB; HostDB:ENSRNOG00000017560; -.
DR   eggNOG; ENOG502S022; Eukaryota.
DR   HOGENOM; CLU_136864_0_0_1; -.
DR   InParanoid; Q9R1S9; -.
DR   OrthoDB; 4608966at2759; -.
DR   PhylomeDB; Q9R1S9; -.
DR   Reactome; R-RNO-201556; Signaling by ALK.
DR   Reactome; R-RNO-9851151; MDK and PTN in ALK signaling.
DR   PRO; PR:Q9R1S9; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000017560; Expressed in ovary and 19 other cell types or tissues.
DR   ExpressionAtlas; Q9R1S9; baseline and differential.
DR   GO; GO:0042995; C:cell projection; IDA:RGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0035374; F:chondroitin sulfate binding; ISS:UniProtKB.
DR   GO; GO:0008083; F:growth factor activity; IBA:GO_Central.
DR   GO; GO:1904399; F:heparan sulfate binding; ISS:UniProtKB.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0030325; P:adrenal gland development; IDA:UniProtKB.
DR   GO; GO:0001662; P:behavioral fear response; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IDA:RGD.
DR   GO; GO:0021681; P:cerebellar granular layer development; ISO:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; ISO:RGD.
DR   GO; GO:0007010; P:cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0030421; P:defecation; ISO:RGD.
DR   GO; GO:0021542; P:dentate gyrus development; ISO:RGD.
DR   GO; GO:0044849; P:estrous cycle; ISS:UniProtKB.
DR   GO; GO:0106091; P:glial cell projection elongation; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0002232; P:leukocyte chemotaxis involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:1904036; P:negative regulation of epithelial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0106015; P:negative regulation of inflammatory response to wounding; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0030279; P:negative regulation of ossification; ISS:UniProtKB.
DR   GO; GO:0045590; P:negative regulation of regulatory T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0048477; P:oogenesis; ISS:UniProtKB.
DR   GO; GO:1905653; P:positive regulation of artery morphogenesis; ISS:UniProtKB.
DR   GO; GO:1905555; P:positive regulation of blood vessel branching; ISS:UniProtKB.
DR   GO; GO:0061036; P:positive regulation of cartilage development; ISS:UniProtKB.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0106016; P:positive regulation of inflammatory response to wounding; ISS:UniProtKB.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:UniProtKB.
DR   GO; GO:0010838; P:positive regulation of keratinocyte proliferation; ISS:UniProtKB.
DR   GO; GO:1904996; P:positive regulation of leukocyte adhesion to vascular endothelial cell; ISS:UniProtKB.
DR   GO; GO:1903039; P:positive regulation of leukocyte cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; ISS:UniProtKB.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; ISS:UniProtKB.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:UniProtKB.
DR   GO; GO:2001224; P:positive regulation of neuron migration; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:2000391; P:positive regulation of neutrophil extravasation; ISS:UniProtKB.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0071673; P:positive regulation of smooth muscle cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; ISS:UniProtKB.
DR   GO; GO:1905564; P:positive regulation of vascular endothelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0050795; P:regulation of behavior; ISO:RGD.
DR   GO; GO:0046850; P:regulation of bone remodeling; ISS:UniProtKB.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0010996; P:response to auditory stimulus; ISS:UniProtKB.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0009611; P:response to wounding; IDA:UniProtKB.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007614; P:short-term memory; ISO:RGD.
DR   GO; GO:0002286; P:T cell activation involved in immune response; ISS:UniProtKB.
DR   GO; GO:0042246; P:tissue regeneration; ISS:UniProtKB.
DR   Gene3D; 2.20.60.10; Pleiotrophin/Midkine, N-terminal domain; 1.
DR   InterPro; IPR000762; Midkine_heparin-bd_GF.
DR   InterPro; IPR020090; PTN/MK_C_dom.
DR   InterPro; IPR038130; PTN/MK_C_dom_sf.
DR   InterPro; IPR020091; PTN/MK_diS_sf.
DR   InterPro; IPR020089; PTN/MK_N_dom.
DR   InterPro; IPR037122; PTN/MK_N_dom_sf.
DR   InterPro; IPR020092; PTN_MK_heparin-bd_GF_CS.
DR   PANTHER; PTHR13850:SF2; MIDKINE; 1.
DR   PANTHER; PTHR13850; PLEIOTROPHIN FAMILY MEMBER; 1.
DR   Pfam; PF01091; PTN_MK_C; 1.
DR   Pfam; PF05196; PTN_MK_N; 1.
DR   PRINTS; PR00269; PTNMIDKINE.
DR   SMART; SM00193; PTN; 1.
DR   SUPFAM; SSF57288; Midkine; 2.
DR   PROSITE; PS00619; PTN_MK_1; 1.
DR   PROSITE; PS00620; PTN_MK_2; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein; Differentiation; Disulfide bond; Growth factor;
KW   Heparin-binding; Mitogen; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000250"
FT   CHAIN           21..140
FT                   /note="Midkine"
FT                   /id="PRO_0000024664"
FT   SITE            100
FT                   /note="Required for high affinity binding to PTRZ1 by
FT                   interacting with the chondroitin sulfate chains of PTRZ1"
FT                   /evidence="ECO:0000250|UniProtKB:P12025"
FT   DISULFID        34..58
FT                   /evidence="ECO:0000250"
FT   DISULFID        42..67
FT                   /evidence="ECO:0000250"
FT   DISULFID        49..71
FT                   /evidence="ECO:0000250"
FT   DISULFID        81..113
FT                   /evidence="ECO:0000250"
FT   DISULFID        91..123
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   140 AA;  15406 MW;  10E340C43AA619CA CRC64;
     MQHRSFFLLA LVALLAVTTA VAKKKDKVKK GSECSEWTWG PCTPSSKDCG MGFREGTCGA
     QTQRIHCKVP CNWKKEFGAD CKYKFESWGA CDGSTGTKAR QGTLKKARYN AQCQETIRVT
     KPCTSKTKSK AKAKKGKGKD
//
